Carmell Therapeutics Corp...

NASDAQ: CTCX · Real-Time Price · USD
0.20
0.01 (2.77%)
At close: Mar 07, 2025, 3:55 PM

Carmell Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.72 -21.67 -29.35
PEG Ratio
-0.01 -0.55 n/a
PS Ratio
n/a n/a n/a
PB Ratio
1.70 -5.19 -6.43
P/FCF Ratio
-5.01 -57.08 -160.61
P/OCF Ratio
-5.03 -57.2 -161.6
OCF/S Ratio
n/a n/a n/a
Debt / Equity Ratio
0.09 -0.1 -0.33
Quick Ratio
1.63 0.08 0.01
Current Ratio
1.63 0.08 0.01
Asset Turnover
n/a n/a n/a
Interest Coverage
-5.87 -1.47 -0.78
Return on Equity
-0.62 0.24 0.22
Return on Assets
-0.24 -5.18 -4.16
Return on Invested Capital
-0.18 2.18 0.49
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
n/a n/a n/a
Net Profit Margin
n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a
Operating Profit Margin
n/a n/a n/a
FCF Margin
n/a n/a n/a
EBITDA Margin
n/a n/a n/a